BrightHeart secures CE mark for AI-powered prenatal ultrasound platform

This authorisation will expand the B-Right AI platform’s use to Europe, as BrightHeart continues to roll the technology out across the US. This authorisation will expand the B-Right AI platform’s use to Europe, as BrightHeart continues to roll the technology out across the US. BrightHeart has secured a CE mark for its AI-powered prenatal ultrasound platform, expanding on the technology’s prior FDA clearance. Credit: dr.D / Shutterstock.com. Parisian medtech company, BrightHeart, has obtained a CE mark for its artificial intelligence (AI)-based tool to optimise the prenatal ultrasound process – marking a commercial expansion for the technology following its prior clearance…

Source: Medical Device Network